Clinical Trials Insight: 700029851
Latest Information Update: 07 Jan 2009
Price :
$35 *
At a glance
- Drugs VX 500 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- Sponsors Vertex Pharmaceuticals
- 14 Jan 2008 New trial record.
Latest Information Update: 07 Jan 2009